Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: Ilaris Adds Three Rare Disease Claims; Sirukumab Submitted; Exondys 51's Surprising Approval

23 Sep 2016

• By Bridget Silverman

Related Content

Still room for innovators in women's health, says Bayer

12 May 2015

Too Little, Too Late For GSK/Janssen's Sirukumab in RA?

13 Jun 2016

Duchenne Surprise: Sarepta Prices Exondys 51 Below Expectations

20 Sep 2016

Bayer Reiterates Pharma Commitment Post-Monsanto, Plays Up Pipeline

20 Sep 2016

Keeping Track: Approvals For Nuplazid, Cabometyx, Bevespi And More; Digital Aripiprazole Tablet Needs More Study

02 May 2016

Keeping Track: Mycapssa Stumbles; Carnexiv Returns; Keytruda Follows Opdivo In Hodgkin Lymphoma

25 Apr 2016

Keeping Track: Approval Elusive For Biosimilar Neulasta; Valeant Gets A Nod And A No From FDA; Submissions From Amgen, Puma, Bristol

22 Jul 2016

Eteplirsen Review Offers Lessons For FDA, Advocacy Groups, Industry

21 Sep 2016

Sarepta's Eteplirsen Approved After Contentious Internal FDA Debate

20 Sep 2016

Eteplirsen Review Timeline: CDER Director Was Involved Early And Often

20 Sep 2016

Duchenne Development: Six-Minute Walk Losing Favor?

21 Sep 2016

Keeping Track: FDA Approves Adlyxin, Accepts Brineura, Lowers Hurdle For Xadago

29 Jul 2016

Related Companies

Sarepta Therapeutics, Inc.

Novartis AG

GSK plc

Johnson & Johnson

Newron Pharmaceuticals S.p.A.

Nicox S.A.

TherapeuticsMD Inc.

Bayer AG

Johnson & Johnson

Genentech, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Bausch Health Companies Inc.

Bausch Health Companies Inc.

Additional Topics

United States Approvals Regulation BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.